Management of Hepatitis C Infection

  • Authors: Jordan J. Feld, MD, MPH; Hemant Shah, MD, MScCH HPTE (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 7/24/18 (What's New)

Summary

  • The risk of HCV reinfection is elevated among persons who inject drugs (PWIDs), HIV-coinfected men who have sex with (MSM), and individuals in correctional settings[Simmons 2016]
  • Long-term follow-up is advised for individuals achieving SVR yet remaining at an increased risk of reinfection
    • AASLD/IDSA guidelines recommend annual HCV RNA testing among individuals with ongoing risk factors for HCV infection (ie, PWID and HIV-coinfected MSM engaging in unprotected sex)[AASLD-IDSA HCV]

Action required

Keywords: Hepatitis C-Treatment

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.